Localization, induction, and functional effects of tau phosphorylated at threonine 217
Early AD biomarker assays based on tau<sub>pT217</sub> detection with antibodies are at risk of artifactual signal inflation unless rigorous steps are taken to ensure antibody specificity. Neuronal levels of tau<sub>pT217</sub> rise steadily in brain as AD progresses. Finally, our collective results raise the possibilities that xcTauOs drive T217 phosphorylation of tau in vivo, and that tau<sub>pT217</sub> contributes to synaptic decline and favors formation of tau-tau interactions at the expense of tau binding to microtubules.
Authors
- George S. Bloom (ORCID: https://orcid.org/0000-0003-4781-7627)
Institutions
- University of Virginia (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.089421
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00